Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Newer Targets
Hepion Pharmaceuticals’ CRV431 Prevents Cirrhosis in Experimental Model of Severe Liver…
Newer Targets
Palleon Pharmaceuticals to Present Preclinical Data on EAGLE-Her2 and Anti-Siglec-9 Antibody…
Newer Targets
Codiak Presents First Preclinical Data for exoASO, Engineered Exosomes Designed to…
Newer Targets
Nkarta Therapeutics Presents Preclinical Data for CD19 CAR NK Program
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Approval
AstraZeneca’s Calquence Wins FDA Approval for Chronic Lymphocytic Leukemia
Phase III
First China-manufactured Trastuzumab Biosimilar HLX02 Global Phase III Trial Met Primary…
Phase II
Abivax Receives French Regulatory Authority (ANSM) Approval to Include French Study…
Approval
BRUKINSA (zanubrutinib) Approved for the Treatment of Mantle Cell Lymphoma, Available…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Deals
AbbVie and Harpoon Expand Partnership with $510 Million Licensing Deal
Acquisitions
Appili Therapeutics Acquires Clinical Stage Antifungal Program From FUJIFILM Toyama Chemical
Deals
Astellas and Welldoc Enter into Strategic Alliance for Digital Therapeutics
Commercial
Eli Lilly to Add 100 Employees Following $400 Million Manufacturing Investment
Home
Clinical
Launch
Launch
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Launch
Intrepida Bio Launches to Develop Novel Medicines that Exploit the Innate Immune System to Fight Disease
Biospace News
-
October 22, 2019
Launch
Sun Pharma Launches Drizalma Sprinkle in the U.S.
Launch
Sun Pharma Launches CEQUA for the Treatment of Dry Eye Disease in the U.S.
Launch
Sun Pharma Launches Ezallor Sprinkle (Rosuvastatin) in the U.S. for People Who Have Difficulty Swallowing
Launch
H2-Pharma and CHEPLAPHARM Announce Launch of ETOPOPHOS Injection
Launch
Clover Health Launches Clover Therapeutics, a New Research Subsidiary to Develop...
Firstwordpharma News
-
July 10, 2019
0
Launch
Century Therapeutics Launches With USD 250M Financing for Induced Pluripotent Stem...
Biospace News
-
July 1, 2019
0
Launch
Century Therapeutics Launches with $250 Million for Induced Pluripotent Stem Cell...
Biospace News
-
July 1, 2019
0
Launch
Lannett Enters Into Distribution Agreement For Dantrolene Capsules, Commences Product Launch
Biospace News
-
June 28, 2019
0
Launch
Nervgen Pharma Launches Multiple Sclerosis Program Targeting Nerve Remyelination
Biospace News
-
June 26, 2019
0
1
2
3
...
9
Page 1 of 9
- Advertisement -
MOST POPULAR
Novus Therapeutics Reports Fourth Quarter and Full-Year 2018 Financial Results and...
March 28, 2019
FSD Pharma Enters into Supply Agreement with Canntab Therapeutics and World...
February 12, 2019
Biohaven Enrolls First Patient in Phase 2 Clinical Trial of Rimegepant,...
July 1, 2019
MorphoSys Presents Results for Fiscal Year 2018
March 13, 2019
Load more
HOT NEWS
Others
ZyVersa Therapeutics Announces Appointment of International Investor, Andrew (DW) Kim, to...
Phase III
Abstract Highlighting New Data from the Iomab-B Pivotal Phase 3 SIERRA...
Respiratory
Eloxx Pharmaceuticals Announces Participation in the HIT-CF Project on Cystic Fibrosis
Others
A Talk With the CEO of CURE Pharmaceutical
